Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
224.60    -2.00 (-0.88%)
Bid:
225.40
Ask:
226.00
Spread: 0.60 (0.266%)
Market Cap: £2.20b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Statement re shareholder consultation

22 Aug 2025 15:00

RNS Number : 4477W
Serco Group PLC
22 August 2025
 

Statement regarding shareholder consultation following the 2024 Annual General Meeting

Serco Group plc ("Serco" or the "Company")

22 August 2025

 

At the Serco Annual General Meeting held on 24 April 2025, all of the resolutions proposed were approved by shareholders. Resolution 2, relating to the approval of the 2024 Directors' Remuneration Report (DRR), passed with a majority of 79.39%. The 80% threshold was therefore not reached. In accordance with the requirements of the UK Corporate Governance Code, the Company provides an update on the views received from shareholders during a period of consultation and what actions have been taken.

 

The 2024 DRR sets out the remuneration for Anthony Kirby, who succeeded Mark Irwin as Group Chief Executive on 1 March 2025. The details of Anthony Kirby's remuneration and the terms of Mark Irwin's retirement set out in the DRR are consistent with the information shared in the announcement published on 13 January 2025 and the subsequent Section 430(2B) statement; and are in line with the Group's overall remuneration policy.

 

As set out in the DRR, Anthony Kirby's base salary was set at 2.5% above the salary of Mark Irwin when he stood down. In determining the base salary for Anthony Kirby, the Company considered a range of relevant external and internal factors, including the size, scope and complexity of the role; pay levels for the same role in similar organisations; and Anthony Kirby's knowledge, skills, and experience. As set out in the DRR, the Remuneration Committee set Anthony Kirby's salary at the same level as Mark Irwin's and took into account the scheduled salary increase that Mark Irwin would have received for 2025 had he remained in the role.

 

The Company regularly engages with shareholders and the Chair of the Remuneration Committee wrote to the Company's top 20 shareholders and the relevant proxy advisors in January 2025, well in advance of the AGM, to explain the decision. The Chair of the Remuneration Committee received no feedback from either shareholders or proxy advisors at that time. Following the 20.61% votes cast against the Resolution 2 at the AGM, the Company contacted the top 20 shareholders again to understand their views on the decisions outlined in the DRR and the reasons why those who voted against took that decision. As with the initial consultation, the feedback received from shareholders did not raise any material concerns.

 

The Company will continue to consider all feedback provided by shareholders and advisors when taking remuneration decisions and ensure that the rationale for the decisions taken is clearly outlined in the relevant Directors' Remuneration Report.

 

Ends.

 

For further information, please contact:

Jamie Hastings, Head of Investor Relations | +44 (0) 7718 195 074 | jamie.hastings@serco.com

Scot Marchbank, Group Communications and Marketing Director | +44 (0) 7958 675 706 | scot.marchbank@serco.com

 

About Serco

Serco brings together the right people, the right technology, and the right partners to create innovative solutions that make a positive impact and address some of the most urgent and complex challenges facing the modern world.

 

With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility, and customer services.

 

Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

 

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery.

 

More information can be found at www.serco.com.

 

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRPKBBDCBKKPFB
Date   Source Headline
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20244:40 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20243:47 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20246:03 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 202410:00 amRNSPublication of the 2023 ARA and 2024 Notice of AGM
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSShare Repurchase Programme
4th Mar 20247:00 amRNSSerco completes acquisition of European Homecare
1st Mar 20245:43 pmRNSAnnual Financial Report
29th Feb 20247:00 amRNS2023 Final Results
2nd Feb 20244:33 pmRNSHolding(s) in Company
29th Jan 20244:46 pmRNSHolding(s) in Company
22nd Jan 202411:36 amRNSHolding(s) in Company
29th Dec 202310:00 amRNSTotal Voting Rights
27th Dec 20232:30 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSAcquisition of leading German immigration business
14th Dec 20237:00 amRNSPre-close trading update
11th Dec 202310:31 amRNSCancellation of Treasury Shares
6th Dec 20231:03 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.